How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...
National security, unlocked. Each Thursday, host Mary Louise Kelly and a team of NPR correspondents discuss the biggest national security news of the week. With decades of reporting from battlefields ...
Terms apply to American Express benefits and offers. Visit americanexpress.com to learn more. Any time you tap, swipe or dip a credit or debit card at checkout or enter your card number online, you ...
Andrew Bloomenthal has 20+ years of editorial experience as a financial journalist and as a financial services marketing writer. Khadija Khartit is a strategy, investment, and funding expert, and an ...
Biological systems often struggle to maintain stable outputs at the single-cell level under noise. Here, authors introduce a noise controller that, when combined with antithetic integral feedback, ...
Alexandra Twin has 15+ years of experience as an editor and writer, covering financial news for public and private companies. Vikki Velasquez is a researcher and writer who has managed, coordinated, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results